carotenoid/atrophy

The invention related to the use of lutein and zeaxanthin which increase the deposition of macular pigment in the human eye. The invention is particularly but not exclusively concerned with lutein and/or zeaxanthin for use in the treatment by therapy or prophylaxis of disease of the macula and in

BACKGROUND OF THE INVENTION There are many disorders characterized by circulatory system problems: Peripheral Vascular Disease The circulatory system consists of two types of blood vessels, arteries and veins, which carry the blood throughout the body. Arteries carry oxygen- and nutrient-rich blood

BACKGROUND OF THE INVENTION There are many disorders characterized by circulatory system problems: Peripheral Vascular Disease The circulatory system consists of two types of blood vessels, arteries and veins, which carry the blood throughout the body. Arteries carry oxygen- and nutrient-rich blood

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention generally relates to methods and compositions to alleviate eye diseases and, more specifically, to improved methods and compositions for the treatment of cataracts and macular degeneration. 2. Description of the Related

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention generally relates to methods and compositions to alleviate eye diseases and, more specifically, to improved methods and compositions for the treatment of cataracts and macular degeneration. 2. Description of the Related

BACKGROUND OF THE INVENTION This invention is in the field of biochemistry, and relates to the creation and purification of a certain isomer of a carotenoid pigment called zeaxanthin (abbreviated as ZX), for use in preventing or treating macular degeneration, a disease which damages retinal tissue

FIELD OF THE INVENTION The present invention relates to methods and compositions for treatment and prevention of disease, and in particular embodiments, disorders of the eye. In an embodiment, the present invention describes linking therapeutic compounds to xanthophyll carotenoids to enhance

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention is in the field of organic chemistry. The invention relates to a process for the synthesis of (3R,3'R)-zeaxanthin and (3R,3'S;meso)-zeaxanthin from a dehydration product of (3R,3'R,6'R)-lutein, namely,

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention is in the field of organic chemistry. The invention relates to a process for the synthesis of (3R,3'R,6'R)-lutein and its stereoisomers from commercially available (rac)-.alpha.-ionone by a C.sub.15+C.sub.10+C.sub.15 coupling

FIELD OF THE INVENTION The present invention relates to a nutritional dietary supplement composition and related methods of administration for the treatment and/or prevention of retinal diseases, and their concomitant impairment of vision. In particular, the invention relates to a nutritional

BACKGROUND OF THE INVENTION This invention is in the field of pharmacology, and relates to human use of a yellow pigment called zeaxanthin (ZX) in preventing or treating macular degeneration, a disease which damages retinal tissue and causes blindness. This application is being simultaneously filed

BACKGROUND OF THE INVENTION This invention is in the field of biochemistry, and relates to the creation and purification of a certain isomer of a carotenoid pigment called zeaxanthin (abbreviated as ZX), for use in preventing or treating macular degeneration, a disease which damages retinal tissue

BACKGROUND OF THE INVENTION This invention is in the field of biochemistry, pharmacology, and nutritional supplements, and relates to a new use for zeaxanthin, a carotenoid found in plants such as spinach, kale, and corn. Numerous efforts have been made to identify drugs or other biomolecules that

FIELD OF THE INVENTION The invention relates to the determination of the freshness of agricultural crops, products, and forests, and in particular, to the determination of antioxidant content through optical methods. BACKGROUND OF THE INVENTION In plants, carotenoids act as accessory pigments in

FIELD OF THE INVENTION This invention is in the field of medicine, and relates to administering a natural carotenoid pigment called zeaxanthin to patients who receive treatment using light-activated drugs to inhibit the unwanted growth of blood vessels in their retinas. BACKGROUND OF THE